← 홈

전체 프로그램

ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-11 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,486개
AntibodystaleGeneMedicine Co., Ltd.Phase 2

Part C (GM103 and Pembrolizumab, GM103 and Pembrolizumab (Part C))

Head and Neck Cancer; Malignant Melanoma · Head and Neck Cancer

#HeadandNeckCancer#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
CGTBiologicstaleEssen BiotechPhase 2

GPC3 CD146 CAR-T cells (GPC3 CD146 CAR-T cells)

Ovarian Cancer; Ovarian Carcinoma · Ovarian Cancer

#OvarianCancer#CGT#Phase2#세포유전치료#CAR-T+3
임상시험 1상태 RECRUITING
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 (GSK 5733584)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+3
임상시험 1상태 RECRUITING
AntibodystaleQuantumLeap Healthcare Collabor…Phase 2

GSK 5733584 + Dostarlimab (GSK 5733584 + Dostarlimab)

Breast Neoplasms; Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+4
임상시험 1상태 RECRUITING
AntibodystaleInsel Gruppe AG, University Hos…Phase 2

durvalumab (Imfinzi, Gemcitabin, Cisplatin and Durvalumab)

Bile Duct Cancer · Bile Duct Cancer

#BileDuctCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 RECRUITING
ADCBiologicstalePeking University Third HospitalPhase 2

Chemotherapy (Gemcitabine, Gemcitabine (Chemotherapy))

Muscle-Invasive Bladder Cancer (MIBC) · Muscle-Invasive Bladder Cancer (MIBC)

#Muscle-InvasiveBladderCancerMIBC#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
AntibodystaleInstitut du Cancer de Montpelli…Phase 2

trastuzumab (Herceptin, Gemcitabine - Trastuzumab - Erlotinib)

Metastatic Pancreatic Adenocarcinoma · Metastatic Pancreatic Adenocarcinoma

#MetastaticPancreaticAdenocarcino#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRoswell Park Cancer InstitutePhase 2

Gemcitabine, Capecitabine and Bevacizumab (Gemcitabine, Capecitabine and Bevacizumab)

Cholangiocarcinoma · Cholangiocarcinoma

#Cholangiocarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGustave Roussy, Cancer Campus, …Phase 2

Gemox, Cetuximab (Gemox, Cetuximab)

Advanced Biliary Cancer · Advanced Biliary Cancer

#AdvancedBiliaryCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleTianjin Medical University Canc…Phase 2

durvalumab (Imfinzi, HAIC+Durvalumab+Tremelimumab+Bevacizumab)

Unrescetable Hepatocellular Carcinoma · Unrescetable Hepatocellular Carcinoma

#UnrescetableHepatocellularCarcin#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 1

HAIC、Bevacizumab、Camrelizumab (HAIC、Bevacizumab、Camrelizumab)

Metastatic Liver Cancer · Metastatic Liver Cancer

#MetastaticLiverCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
ADCBiologicstaleCSPC Megalith Biopharmaceutical…Phase 2

HB1901 (HB1901)

Advanced Breast Cancer · Advanced Breast Cancer

#AdvancedBreastCancer#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
CGTBiologicstaleFuda Cancer Hospital, GuangzhouPhase 2

HER-2-targeting CAR T Cells infusion (HER-2-targeting CAR T Cells infusion)

Breast Cancer · Breast Cancer

#BreastCancer#CGT#Phase2#세포유전치료#CAR-T+2
임상시험 1상태 DISCONTINUED
AntibodystaleUniversity of VirginiaPhase 2

pembrolizumab (Keytruda, HER2 BATs with Pembrolizumab)

Metastatic Breast Cancer · HER2

#HER2#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
ADCBiologicstaleNovartis PharmaceuticalsPhase 1

HKT288 (HKT288)

Epithelial Ovarian Cancer; Renal Cell Carcinoma · Epithelial Ovarian Cancer

#EpithelialOvarianCancer#ADC#Phase1#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 DISCONTINUED
ADCBiologicstaleShanghai Henlius BiotechPhase 2

HLX43 DOSE1 IN 1L TNBC (HLX43 DOSE1 IN 1L TNBC)

Breast Cancer (Triple Negative Breast Cancer (TNBC)) · Breast Cancer (Triple Negative Breast Ca

#BreastCancerTripleNegativeBreast#ADC#Phase2#항체약물접합체#antibody-drug-conjugate+1
임상시험 1상태 RECRUITING
ADCBiologicstaleShanghai Henlius BiotechPhase 3

HLX87+HX22 (HLX87+HX22)

HER2 + Breast Cancer · HER2

#HER2#ADC#Phase3#항체약물접합체#antibody-drug-conjugate+2
임상시험 1상태 RECRUITING
CGTBiologicstaleTCRCure Biopharma Ltd.Phase 1

HPV E6-specific TCR-T cells (HPV E6-specific TCR-T cells)

Cervical Cancer; Head and Neck Squamous Cell Carcinoma · Cervical Cancer

#CervicalCancer#CGT#Phase1#세포유전치료#CAR-T+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 3

HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleRochePhase 3

HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab (HR070803 simulator plus oxaliplatin, 5-FU/LV, bevacizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 RECRUITING

48 / 75 페이지

← 이전다음 →